Medication info
Posnel Plus Tablet

Posnel Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablets
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201604118 · Approved 2016.06.30 · Insurance code 653403650

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet orally once weekly 2. Elderly patients: Since the bioavailability and pharmacokinetics of this drug in elderly patients (60 years of age or older) are similar to those in younger people, no dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is required for patients with creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment with creatinine clearance below 30ml/min. Since food interferes with the absorption of this drug, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time during the day. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking the drug. Patients should take supplements if their dietary intake of calcium and vitamin D is inadequate. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This drug, taken once weekly, provides a week's supply at 800 IU of vitamin D daily. If a patient forgets to take the drug on the scheduled day, take it on the day it is remembered. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.
Child dose
3. Children: Safety and efficacy have not been established in children and growing adolescents.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used to treat and prevent osteoporosis in both postmenopausal women and men.

How to take

Adult dose

1. Adults: Administer 1 tablet orally once weekly 2. Elderly patients: Since the bioavailability and pharmacokinetics of this drug in elderly patients (60 years of age or older) are similar to those in younger people, no dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is required for patients with creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment with creatinine clearance below 30ml/min. Since food interferes with the absorption of this drug, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time during the day. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking the drug. Patients should take supplements if their dietary intake of calcium and vitamin D is inadequate. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This drug, taken once weekly, provides a week's supply at 800 IU of vitamin D daily. If a patient forgets to take the drug on the scheduled day, take it on the day it is remembered. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.

Child dose

3. Children: Safety and efficacy have not been established in children and growing adolescents.

Precautions

This medication may irritate the gastrointestinal mucosa and cause esophageal problems such as esophagitis or esophageal ulcers. It must be taken with a sufficient amount of water, and the patient should not lie down for at least 30 minutes after taking the medication. If any abnormal symptoms in the esophagus occur, discontinue use immediately and consult a physician. Patients with esophageal strictures, achalasia, or severe kidney impairment should not take this medication. Those with specific genetic diseases like lactose intolerance should also avoid this medication. Caution should be exercised by individuals allergic to Yellow No. 5 dye. This medication can cause various side effects, including dyspepsia, muscle pain, joint pain, and skin rash. In particular, rare but serious side effects such as osteonecrosis of the jaw can occur in osteoporosis patients, making oral hygiene management crucial. It is important to ensure adequate intake of calcium and vitamin D, and supplements should be taken if necessary. Medications or drinks containing calcium, magnesium, or iron can interfere with the absorption of this medication, so they should not be taken together. Women who are pregnant or breastfeeding must consult a physician before taking this medication. Safety in children has not been established, so caution is needed for its use. In cases of overdose, symptoms of hypocalcemia may occur, necessitating immediate medical attention. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • decreased blood calcium
Show 105 more
  • decreased blood phosphorus
  • bone pain
  • joint pain
  • muscle pain
  • iritis
  • uveitis
  • liver dysfunction
  • jaundice
  • external ear osteonecrosis
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • angioedema
  • rash
  • blister
  • skin reaction
  • urinary tract infection
  • cystitis
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • abdominal distension
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • joint abnormalities
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension headache
  • sensory disturbances
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • fibromyalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • cough
  • hypercholesterolemia
  • heartburn
  • epigastric pain
  • loss of appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial edema
  • hair loss
  • abnormal olfaction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light orange oval film-coated tablets

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.